CLINICAL_TRIALS
trial_result
· 2011-03-04
Clinical Trial Update: A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer [Phase 4]
Summary
Phase 4 clinical trial update evaluating Xeloda (capecitabine) in women with HER2-negative metastatic breast cancer; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2011-03-04